Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Linder, MW; Valdes, R
   Genetic mechanisms for variability in drug response and toxicity
   JOURNAL OF ANALYTICAL TOXICOLOGY
   
   M.W. Linder e R. Valdes, "Genetic mechanisms for variability in drug response and toxicity", J ANAL TOX, 25(5), 2001, pp. 405-413
2. Leeder, JS
   Pharmacogenetics and pharmacogenomics
   PEDIATRIC CLINICS OF NORTH AMERICA
   
   J.S. Leeder, "Pharmacogenetics and pharmacogenomics", PED CLIN NA, 48(3), 2001, pp. 765
3. Sandborn, WJ
   The role of genetics (pharmacogenetics) in the treatment of inflammatory bowel disease in the future
   DRUGS OF TODAY
   
   W.J. Sandborn, "The role of genetics (pharmacogenetics) in the treatment of inflammatory bowel disease in the future", DRUGS TODAY, 37, 2001, pp. 263-273
4. Rusnak, JM; Kisabeth, RM; Herbert, DP; McNeil, DM
   Pharmacogenomics: Aa clinician's primer on emerging technologies for improved patient care
   MAYO CLINIC PROCEEDINGS
   
   J.M. Rusnak et al., "Pharmacogenomics: Aa clinician's primer on emerging technologies for improved patient care", MAYO CLIN P, 76(3), 2001, pp. 299-309
5. Lowry, PW; Franklin, CL; Weaver, AL; Szumlanski, CL; Mays, DC; Loftus, EV; Tremaine, WJ; Lipsky, JJ; Weinshilboum, RM; Sandborn, WJ
   Leucopenia resulting from a drug interaction between azathioprine or 6-mercaptopurine and mesalamine, sulphasalazine, or balsalazide
   GUT
   
   P.W. Lowry et al., "Leucopenia resulting from a drug interaction between azathioprine or 6-mercaptopurine and mesalamine, sulphasalazine, or balsalazide", GUT, 49(5), 2001, pp. 656-664
6. Emilien, G; Ponchon, M; Caldas, C; Isacson, O; Maloteaux, JM
   Impact of genomics on drug discovery and clinical medicine
   QJM-MONTHLY JOURNAL OF THE ASSOCIATION OF PHYSICIANS
   
   G. Emilien et al., "Impact of genomics on drug discovery and clinical medicine", QJM-MON J A, 93(7), 2000, pp. 391-423
7. Lau, KF; Sakul, H
   Pharmacogenomics
   ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 35
   
   K.F. Lau e H. Sakul, "Pharmacogenomics", ANNU REP M, 35, 2000, pp. 261-269
8. Linder, MW; Valdes, R
   Pharmacogenetics in the practice of laboratory medicine
   MOLECULAR DIAGNOSIS
   
   M.W. Linder e R. Valdes, "Pharmacogenetics in the practice of laboratory medicine", MOL DIAGN, 4(4), 1999, pp. 365-379
9. Rowland, K; Lennard, L; Lilleyman, JS
   In vitro metabolism of 6-mercaptopurine by human liver cytosol
   XENOBIOTICA
   
   K. Rowland et al., "In vitro metabolism of 6-mercaptopurine by human liver cytosol", XENOBIOTICA, 29(6), 1999, pp. 615-628
10. SCHMIEGELOW K
    MAINTENANCE CHEMOTHERAPY OF ACUTE LYMPHOBLASTIC-LEUKEMIA IN CHILDREN - CLINICAL AND PHARMACOLOGICAL ASPECTS OF THE MONITORING AND ADJUSTMENT OF ORAL METHOTREXATE AND 6-MERCAPTOPURINE DOSAGE
    Danish medical bulletin
    
    K. Schmiegelow, "MAINTENANCE CHEMOTHERAPY OF ACUTE LYMPHOBLASTIC-LEUKEMIA IN CHILDREN - CLINICAL AND PHARMACOLOGICAL ASPECTS OF THE MONITORING AND ADJUSTMENT OF ORAL METHOTREXATE AND 6-MERCAPTOPURINE DOSAGE", Danish medical bulletin, 45(5), 1998, pp. 510-532